107 related articles for article (PubMed ID: 6761000)
1. Alteration of polypeptide backbone structure as determined by circular dichroic spectral analysis in relation to change of plasminogen activator activity of two forms of human urinary urokinase denatured with guanidine hydrochloride.
Miwa N; Yamashita A; Suzuki A
Chem Pharm Bull (Tokyo); 1982 Oct; 30(10):3669-78. PubMed ID: 6761000
[No Abstract] [Full Text] [Related]
2. Comparative studies on two active enzyme forms of human urinary urokinase. II. pH-and heat-stabilities of plasminogen activator activity.
Miwa N; Obata Y; Suzuki A
Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):472-5. PubMed ID: 7023710
[No Abstract] [Full Text] [Related]
3. Isoelectric points of two molecular forms of human urinary urokinase determined by density-gradient isoelectric focusing and isotachoelectrophoresis.
Miwa N; Sawada T; Suzuki A
Chem Pharm Bull (Tokyo); 1982 Apr; 30(4):1513-6. PubMed ID: 7049421
[No Abstract] [Full Text] [Related]
4. Tyrosyl residues of two molecular forms of human urinary urokinase: their ionization mode characterized by spectrophotometric and CD titrations and reactivity with cyanuric fluoride in relation to enzymic activity.
Miwa N; Sawada T; Suzuki A
Biochem Biophys Res Commun; 1982 Oct; 108(3):1136-43. PubMed ID: 6758771
[No Abstract] [Full Text] [Related]
5. Comparative studies on two active enzyme forms of human urinary urokinase. I. Purification by serial column chromatography and homogeneity analyses of molecular weight and isoelectric point.
Miwa N; Takayanagi H; Suzuki A
Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):463-71. PubMed ID: 7023709
[No Abstract] [Full Text] [Related]
6. Comparative studies on urokinase and plasminogen activator from cultured pancreatic carcinoma.
Wu MC; Yunis AA
Int J Biochem; 1979; 10(12):1001-6. PubMed ID: 116877
[No Abstract] [Full Text] [Related]
7. Purification and partial characterization of a single-chain high-molecular-weight form of urokinase from human urine.
Husain SS; Gurewich V; Lipinski B
Arch Biochem Biophys; 1983 Jan; 220(1):31-8. PubMed ID: 6338833
[TBL] [Abstract][Full Text] [Related]
8. Free energy changes in ribonuclease A denaturation. Effect of urea, guanidine hydrochloride, and lithium salts.
Ahmad F
J Biol Chem; 1983 Sep; 258(18):11143-6. PubMed ID: 6885815
[TBL] [Abstract][Full Text] [Related]
9. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
10. Human low-molecular-weight urinary urokinase. Partial characterization and preliminary sequence data of the two polypeptide chains.
Schaller J; Nick H; Rickli EE; Gillessen D; Lergier W; Studer RO
Eur J Biochem; 1982 Jul; 125(2):251-7. PubMed ID: 6749491
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator (urokinase) from cultured cells.
Lewis LJ
Thromb Haemost; 1979 Oct; 42(3):895-900. PubMed ID: 505404
[TBL] [Abstract][Full Text] [Related]
12. On the denaturation of porcine erythrocyte catalase with alkali, urea, and guanidine hydrochloride in relation to its subunit structure.
Takeda A; Hirano K; Shiroya Y; Samejima T
J Biochem; 1983 Apr; 93(4):967-75. PubMed ID: 6863240
[TBL] [Abstract][Full Text] [Related]
13. Conformational studies on plasminogen activator inhibitor (PAI-1) in active, latent, substrate, and cleaved forms.
Sancho E; Declerck PJ; Price NC; Kelly SM; Booth NA
Biochemistry; 1995 Jan; 34(3):1064-9. PubMed ID: 7827021
[TBL] [Abstract][Full Text] [Related]
14. Competing solvent effects of polyols and guanidine hydrochloride on protein stability.
Gekko K; Ito H
J Biochem; 1990 Apr; 107(4):572-7. PubMed ID: 2358430
[TBL] [Abstract][Full Text] [Related]
15. Unfolding and refolding of the reduced constant fragment of the immunoglobulin light chain. Kinetic role of the intrachain disulfide bond.
Goto Y; Hamaguchi K
J Mol Biol; 1982 Apr; 156(4):911-26. PubMed ID: 6811754
[No Abstract] [Full Text] [Related]
16. [Plasminogen activators in assessing the reaction of patients with chronic obstructive bronchitis to physical loading].
Dovgan' AA
Lik Sprava; 1992 Aug; (8):39-41. PubMed ID: 1475923
[TBL] [Abstract][Full Text] [Related]
17. Identification of subpopulations of human urinary plasminogen activators.
Hart DA; Kramer R; Cieplak W
Thromb Haemost; 1984 Apr; 51(2):212-6. PubMed ID: 6539958
[TBL] [Abstract][Full Text] [Related]
18. [Urinary urokinase and blood fibrinolytic activity in patients with diabetes mellitus].
Kaniak J; Kotschy M; Janukowicz-Lorenz H; Plamieniak L
Pol Tyg Lek; 1975 Dec; 30(48):1889-91. PubMed ID: 1197079
[No Abstract] [Full Text] [Related]
19. Conformational changes in human urokinase induced by a specific reduction of disulfide bond in Cys-194-Cys-222 associated with exhibition of enzymatic activity.
Miwa N; Sawada T; Suzuki A
Biochim Biophys Acta; 1984 Nov; 791(1):1-8. PubMed ID: 6498202
[TBL] [Abstract][Full Text] [Related]
20. Compactness of thermally and chemically denatured ribonuclease A as revealed by volume and compressibility.
Tamura Y; Gekko K
Biochemistry; 1995 Feb; 34(6):1878-84. PubMed ID: 7849047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
